Insider · CIK 0001783774
Tony Kin Shun Cheng
Files at RGA (REINSURANCE GROUP OF AMERICA INC). First filing -, latest -.
Tony Kin Shun Cheng files SEC Form 4 as CEO, president and director at RGA (REINSURANCE GROUP OF AMERICA INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tony Kin Shun Cheng has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | AGrant or award Stock Appreciation Right (right to purchase) 2026derivative | +32,767 | $0.00 | $0 | 32,767 | Apr 27, 2026 |
| Mar 12, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Common stock | +17,388 | $205.00 | $3.6M | 50,123 | Mar 16, 2026 |
| Mar 12, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | FTax withholding Common stock | -6,715 | $205.00 | $1.4M | 43,408 | Mar 16, 2026 |
| Mar 12, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Performance Contingent Shares 2026derivative | -17,388 | $0.00 | $0 | 0 | Mar 16, 2026 |
| Feb 10, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Common stock | +4,152 | $93.53 | $388k | 34,521 | Feb 11, 2026 |
| Feb 10, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | FTax withholding Common stock | -1,786 | $217.51 | $388k | 32,735 | Feb 11, 2026 |
| Feb 10, 2026 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Stock Appreciation Right (right to purchase) 2016derivative | -4,152 | $0.00 | $0 | 0 | Feb 11, 2026 |
| Mar 14, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | AGrant or award Common stock | +7,140 | $186.01 | $1.3M | 31,778 | Mar 18, 2025 |
| Mar 14, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | FTax withholding Common stock | -1,409 | $186.01 | $262k | 30,369 | Mar 18, 2025 |
| Mar 6, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | AGrant or award Stock Appreciation Right (right to purchase) 2025derivative | +26,532 | $193.00 | $5.1M | 26,532 | Mar 10, 2025 |
| Jan 21, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Common stock | +1,808 | - | - | 24,939 | Jan 23, 2025 |
| Jan 21, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | FTax withholding Common stock | -301 | $223.86 | $67k | 24,638 | Jan 23, 2025 |
| Jan 21, 2025 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Restricted Share Unit - March 2022derivative | -1,808 | - | - | 0 | Jan 23, 2025 |
| Dec 18, 2024 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Common stock | +3,411 | $90.06 | $307k | 25,490 | Dec 20, 2024 |
| Dec 18, 2024 | RGA REINSURANCE GROUP OF AMERICA INC | FTax withholding Common stock | -2,359 | $201.26 | $475k | 23,131 | Dec 20, 2024 |
| Dec 18, 2024 | RGA REINSURANCE GROUP OF AMERICA INC | MOption exercise Stock Appreciation Right (right to purchase) 2015derivative | -3,411 | $0.00 | $0 | 0 | Dec 20, 2024 |
Questions about Tony Kin Shun Cheng
Answered from the filings on this page, as of the latest one.
Is Tony Kin Shun Cheng buying or selling?
Tony Kin Shun Cheng has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tony Kin Shun Cheng's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tony Kin Shun Cheng has 0.
Where does Tony Kin Shun Cheng file Form 4?
Tony Kin Shun Cheng has filed Form 4 at RGA (REINSURANCE GROUP OF AMERICA INC) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.